“Staying Ahead of the Game”: Hogan Lovells hosts in-depth discussion on issues shaping the future of the pharma industry

Taking place in Zurich, this recent event is the latest in a series of international initiatives which form part of Hogan Lovells’ Life Sciences and Health Care Horizons program that aims to help participants understand and take on the key industry trends, both in local markets and globally, with speakers and topics spanning EMEA, the UK, and U.S.  Bringing together perspectives from around the world, these events provide the opportunity to get together to exchange the latest on regulatory advances and opportunities in this crucial sector.

Key topics covered during the proceedings comprised developments impacting AI and digital health as well as insights into the EU Pharma regulatory package, including the proposed changes to regulatory incentives, HTA reform at the EU level, and how the U.S. Inflation Reduction Act (IRA) will impact both U.S. and European markets. 

The multinational team from Hogan Lovells which led the discussions included co-head of Hogan Lovells Life Sciences and Health Care sector Jane Summerfield, and partners Melissa K. Bianchi, Charlotte Damiano, Patrice Navarro, Fabien Roy, Christian Ritz, Mikael Salmela, Dr. Jörg Schickert, Arne Thiermann, Hein Van den Bos as well as counsel Giuseppe Aminzade and senior associate Álvaro Abad.  External speakers included: Marc Bauer (VP & Head of International Operations) from Mirati Therapeutics, Alejandro Bes (Global Head Legal, Customer Engagement, Platforms and Data) and Ioana Ratescu (Legal Head, Regulatory Europe) from Novartis, Axel Korth (Senior Advisor) from EUCOPE and Esther Van Weert (Senior Director) from Apellis Pharmaceuticals.

Read more key takeaways from the program here.